The multiplex PCR assays market size is projected to be worth US$ 1.3 billion in 2023. The market is likely to surpass US$ 3.0 billion by 2033 at a CAGR of 8.5% during the forecast period. The global burden of infectious diseases, such as respiratory infections, sexually transmitted infections, and gastrointestinal infections, continues to rise. Multiplex PCR assays play a crucial role in the diagnosis and surveillance of these diseases by enabling the simultaneous detection of multiple pathogens. The increasing prevalence of infectious diseases is expected to drive the demand for multiplex PCR assays.
Other Drivers Propelling the Demand for Multiplex PCR Assays Market include:
Challenges for Companies /Manufacturers in the Multiplex PCR Assays Market:
Opportunities in the Multiplex PCR Assays Industry:
Latest Trends in the Multiplex PCR Assays Market:
| Attributes | Details |
|---|---|
| Multiplex PCR Assays Market Size (2023) | US$ 1.3 billion |
| Multiplex PCR Assays Market Projected Size (2033) | US$ 3.0 billion |
| Value CAGR (2023 to 2033) | 8.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global multiplex PCR assays market experienced a CAGR of 7.8%, reaching a market size of US$ 1.3 billion in 2023.
Multiplex PCR assays play a vital role in diagnostic applications, particularly in infectious disease testing. The need for rapid and accurate detection of multiple pathogens in a single test is driving the demand for multiplex PCR assays. With the increasing prevalence of infectious diseases, such as respiratory infections, sexually transmitted infections, and hospital-acquired infections, the demand for multiplex PCR assays is expected to grow.
Future Forecast for Multiplex PCR Assays Industry:
Looking ahead, the global multiplex PCR assays market is expected to rise at a CAGR of 8.5% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 3.0 billion by 2033.
Point-of-care (POC) and decentralized testing are gaining prominence in healthcare. Multiplex PCR assays offer the potential for on-site, rapid, and accurate diagnosis in settings such as clinics, emergency departments, and resource-limited areas. The demand for multiplex PCR assays in POC and decentralized testing is expected to increase as the focus on accessible and timely diagnostics grows.
| Country | The United States |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 740.9 million |
| CAGR % 2023 to End of Forecast (2033) | 7.1% |
The multiplex PCR assays market in the United States is expected to reach a market size of US$ 740.9 billion by 2033, expanding at a CAGR of 7.1%. The USA has a substantial burden of infectious diseases, including respiratory infections, sexually transmitted infections, and healthcare-associated infections. The increasing demand for accurate and comprehensive infectious disease testing is driving the growth of the multiplex PCR assays market in the USA
| Country | The United Kingdom |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 146.9 million |
| CAGR % 2023 to End of Forecast (2033) | 8.7% |
The multiplex PCR assays market in the United Kingdom is expected to reach a market value of US$ 146.9 billion, expanding at a CAGR of 8.7% during the forecast period. The UK has a strong research and development landscape, with renowned academic institutions, biotechnology companies, and pharmaceutical companies actively engaged in life sciences research. Multiplex PCR assays are widely utilized in research laboratories for their ability to detect multiple targets simultaneously. The expanding research and development activities across diverse fields, such as genomics, oncology, and infectious diseases, are driving the demand for multiplex PCR assays in the UK.
| Country | China |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 188.7 billion |
| CAGR % 2023 to End of Forecast (2033) | 6.6% |
The multiplex PCR assays market in China is anticipated to reach a market size of US$ 188.7 billion by the end of 2033, growing at a CAGR of 6.6% throughout the forecast period. China has faced several epidemics and disease outbreaks in the past, which has heightened the focus on epidemic and disease control measures. Multiplex PCR assays play a critical role in rapid and accurate diagnosis, surveillance, and control of infectious diseases. The emphasis on epidemic and disease control drives the demand for multiplex PCR assays as essential tools in public health initiatives.
| Country | Japan |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 115.0 billion |
| CAGR % 2023 to End of Forecast (2033) | 7.0% |
The multiplex PCR assays market in Japan is estimated to reach a market size of US$ 115.0 billion by 2033, expected to thrive at a CAGR of 7.0%. Japan has made significant investments in healthcare infrastructure and technology, leading to advancements in diagnostics and molecular testing. The country has witnessed improvements in laboratory facilities, research capabilities, and access to advanced diagnostic technologies. These developments create a favorable environment for the adoption of multiplex PCR assays in Japan.
| Country | South Korea |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 51.9 billion |
| CAGR % 2023 to End of Forecast (2033) | 4.7% |
The multiplex PCR assays market in South Korea is expected to reach a market size of US$ 51.9 billion, expanding at a CAGR of 4.7% during the forecast period. South Korea’s biotechnology and pharmaceutical industries have been growing rapidly in recent years. The country has made significant investments in research and development, fostering innovation in life sciences. Multiplex PCR assays find applications in various research and clinical areas, making them valuable tools for biotech and pharma companies. The expansion of these industries fuels the demand for multiplex PCR assays in South Korea.
Principal Consultant
Instrument segment dominated the multiplex PCR assays market with a market share of 53.5% in 2022. Instruments typically have a longer lifespan compared to consumables. Once purchased, instruments can be used for several years with proper maintenance and calibration. In contrast, consumables such as PCR reagents, primers, probes, and plates are required for each assay and need to be replenished regularly. The lower replacement frequency of instruments compared to consumables contributes to their dominance in the market.
Based on assay type, planar assay segment has dominated the category withholding the significant share of the market at around 64.5% at the end of 2022. Planar assays offer the ability to simultaneously detect and analyze multiple targets in a single assay. They enable the parallel detection of multiple DNA or RNA sequences, gene mutations, or protein markers in a high-throughput manner. This multiplexing capability is crucial for applications that require the simultaneous analysis of multiple targets, such as genotyping, mutation screening, gene expression profiling, and pathogen detection.
By application, research and development segment is expected to continue leading the market over a CAGR of 9.2% throughout the projected timeframe. Multiplex PCR assays simplify experimental workflows in research and development. By consolidating multiple targets into a single assay, researchers can reduce the number of experimental steps, including DNA extraction, PCR setup, and sample handling. This streamlining of workflows minimizes the risk of errors, improves reproducibility, and enhances overall experimental efficiency.
The biopharmaceutical companies have led the multiplex PCR assays market as the leading end user with the market share of 40.7% in 2022. Biopharmaceutical companies are engaged in the research and development of new drugs and therapies. Multiplex PCR assays play a crucial role in the early stages of drug discovery by enabling the simultaneous analysis of multiple genes, biomarkers, or mutations associated with diseases or drug responses. These assays help in identifying potential drug targets, characterizing patient populations, and assessing the efficacy and safety of candidate drugs.
The multiplex PCR assays industry includes several key players that are actively involved in the development, manufacturing, and distribution of multiplex PCR assay products. Manufacturers are heavily investing in the research and developments activities to come up with novel products in the industry.
Key Strategies Used by the Participants
Key players continuously invest in research and development to introduce innovative products. They strive to develop assays with improved sensitivity, specificity, accuracy, and ease of use.
Key players often form strategic partnerships and collaborations with other companies, research institutions, and healthcare organizations. These partnerships can lead to knowledge sharing, joint product development, and expanded market reach.
Expanding into emerging markets with growing healthcare infrastructure and rising demand for multiplex PCR assays allows companies to tap into new opportunities and gain a competitive edge.
Companies in the market may engage in mergers or acquisitions to streamline their product portfolio, obtain new technologies, enter new market niches, and gain access to novel products or intellectual property.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Multiplex PCR Assays Market:
The global multiplex PCR assays market is expected to reach a valuation of US$ 1.3 billion by 2023.
The multiplex PCR assays market demand is set to expand by 8.5% during the assessment period.
The instrument segment is projected to hold the dominant share of the market.
The market is predicted to exceed US$ 3.0 billion by 2033.
The North America offers key opportunities for new entrants in the multiplex PCR assays market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Product Features/ USPs 4.3. Technological Roadmap 4.4. Installed base Scenario 4.5. Regulatory Landscape 4.6. PESTEL Analysis 4.7. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Life Expectancy Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Increasing Cases of Infectious Diseases 5.2.3. Favourable Government Regulations 5.2.4. Growth in Biopharmaceutical Companies 5.2.5. Technological Advancement in the Devices 5.2.6. Increasing Cancer Prevalence 5.2.7. Growing Research and Development 5.2.8. Frequency of Product Approvals 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2017 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product and Services 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product and Services 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product and Services, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product and Services, 2023 to 2033 9.3.1. Consumables 9.3.2. Instruments 9.3.3. Software and Services 9.4. Market Attractiveness Analysis By Product and Services 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Assay Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Assay Type, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Assay Type, 2023 to 2033 10.3.1. Planar Assays 10.3.1.1.1. Blends Protein Arrays (Multiplexed ELISA) 10.3.1.1.2. Antibody Arrays 10.3.2. Bead-based Assays 10.3.2.1.1. Magnetic Bead-based 10.3.2.1.2. Non-magnetic Bead-based 10.4. Market Attractiveness Analysis By Assay Type 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 11.3.1. Disease Diagnosis 11.3.1.1.1. Infectious Disease 11.3.1.1.2. Cancer 11.3.1.1.3. Autoimmune Disease 11.3.1.1.4. Other Diseases 11.3.2. Research and Development 11.3.3. Other Application 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 12.3.1. Biopharmaceutical Companies 12.3.2. Clinical Research Organizations 12.3.3. Academic Research Institutes 12.3.4. Diagnostic Centers 12.3.5. Others 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. USA 14.3.1.2. Canada 14.3.2. By Product and Services 14.3.3. By Assay Type 14.3.4. By Application 14.3.5. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product and Services 14.4.3. By Assay Type 14.4.4. By Application 14.4.5. By End User 14.5. Country Level Analysis & Forecast 14.5.1. USA Market Analysis 14.5.1.1. .Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product and Services 14.5.1.2.2. By Assay Type 14.5.1.2.3. By Application 14.5.1.2.4. By End User 14.5.2. Canada Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product and Services 14.5.2.2.2. By Assay Type 14.5.2.2.3. By Application 14.5.2.2.4. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product and Services 15.3.3. By Assay Type 15.3.4. By Application 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product and Services 15.4.3. By Assay Type 15.4.4. By Application 15.4.5. By End User 15.5. Country Level Analysis & Forecast 15.5.1. Brazil Market Analysis 15.5.1.1. .Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product and Services 15.5.1.2.2. By Assay Type 15.5.1.2.3. By Application 15.5.1.2.4. By End User 15.5.2. Mexico Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product and Services 15.5.2.2.2. By Assay Type 15.5.2.2.3. By Application 15.5.2.2.4. By End User 15.5.3. Argentina Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product and Services 15.5.3.2.2. By Assay Type 15.5.3.2.3. By Application 15.5.3.2.4. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. France 16.3.1.3. Italy 16.3.1.4. UK 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Rest of Europe 16.3.2. By Product and Services 16.3.3. By Assay Type 16.3.4. By Application 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product and Services 16.4.3. By Assay Type 16.4.4. By Application 16.4.5. By End User 16.5. Country Level Analysis & Forecast 16.5.1. Germany Market Analysis 16.5.1.1. .Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product and Services 16.5.1.2.2. By Assay Type 16.5.1.2.3. By Application 16.5.1.2.4. By End User 16.5.2. France Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product and Services 16.5.2.2.2. By Assay Type 16.5.2.2.3. By Application 16.5.2.2.4. By End User 16.5.3. Italy Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product and Services 16.5.3.2.2. By Assay Type 16.5.3.2.3. By Application 16.5.3.2.4. By End User 16.5.4. UK Market Analysis 16.5.4.1. .Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product and Services 16.5.4.2.2. By Assay Type 16.5.4.2.3. By Application 16.5.4.2.4. By End User 16.5.5. Spain Market Analysis 16.5.5.1. .Introduction 16.5.5.2. Market Analysis and Forecast by Market Taxonomy 16.5.5.2.1. By Product and Services 16.5.5.2.2. By Assay Type 16.5.5.2.3. By Application 16.5.5.2.4. By End User 16.5.6. Russia Market Analysis 16.5.6.1. .Introduction 16.5.6.2. Market Analysis and Forecast by Market Taxonomy 16.5.6.2.1. By Product and Services 16.5.6.2.2. By Assay Type 16.5.6.2.3. By Application 16.5.6.2.4. By End User 16.5.7. BENELUX Market Analysis 16.5.7.1. .Introduction 16.5.7.2. Market Analysis and Forecast by Market Taxonomy 16.5.7.2.1. By Product and Services 16.5.7.2.2. By Assay Type 16.5.7.2.3. By Application 16.5.7.2.4. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product and Services 17.3.3. By Assay Type 17.3.4. By Application 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product and Services 17.4.3. By Assay Type 17.4.4. By Application 17.4.5. By End User 17.5. Country Level Analysis & Forecast 17.5.1. India Market Analysis 17.5.1.1. .Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product and Services 17.5.1.2.2. By Assay Type 17.5.1.2.3. By Application 17.5.1.2.4. By End User 17.5.2. Thailand Market Analysis 17.5.2.1. .Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product and Services 17.5.2.2.2. By Assay Type 17.5.2.2.3. By Application 17.5.2.2.4. By End User 17.5.3. Indonesia Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product and Services 17.5.3.2.2. By Assay Type 17.5.3.2.3. By Application 17.5.3.2.4. By End User 17.5.4. Malaysia Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Product and Services 17.5.4.2.2. By Assay Type 17.5.4.2.3. By Application 17.5.4.2.4. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product and Services 18.3.3. By Assay Type 18.3.4. By Application 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product and Services 18.4.3. By Assay Type 18.4.4. By Application 18.4.5. By End User 18.5. Country Level Analysis & Forecast 18.5.1. China Market Analysis 18.5.1.1. .Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product and Services 18.5.1.2.2. By Assay Type 18.5.1.2.3. By Application 18.5.1.2.4. By End User 18.5.2. Japan Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product and Services 18.5.2.2.2. By Assay Type 18.5.2.2.3. By Application 18.5.2.2.4. By End User 18.5.3. South Korea Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product and Services 18.5.3.2.2. By Assay Type 18.5.3.2.3. By Application 18.5.3.2.4. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product and Services 19.3.3. By Assay Type 19.3.4. By Application 19.3.5. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product and Services 19.4.3. By Assay Type 19.4.4. By Application 19.4.5. By End User 19.5. Country Level Analysis & Forecast 19.5.1. Australia Market Analysis 19.5.1.1. .Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product and Services 19.5.1.2.2. By Assay Type 19.5.1.2.3. By Application 19.5.1.2.4. By End User 19.5.2. New Zealand Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product and Services 19.5.2.2.2. By Assay Type 19.5.2.2.3. By Application 19.5.2.2.4. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Türkiye 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product and Services 20.3.3. By Assay Type 20.3.4. By Application 20.3.5. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product and Services 20.4.3. By Assay Type 20.4.4. By Application 20.4.5. By End User 20.5. Country Level Analysis & Forecast 20.5.1. GCC Countries Market Analysis 20.5.1.1. .Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Product and Services 20.5.1.2.2. By Assay Type 20.5.1.2.3. By Application 20.5.1.2.4. By End User 20.5.2. Türkiye Market Analysis 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Product and Services 20.5.2.2.2. By Assay Type 20.5.2.2.3. By Application 20.5.2.2.4. By End User 20.5.3. Northern Africa Market Analysis 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Product and Services 20.5.3.2.2. By Assay Type 20.5.3.2.3. By Application 20.5.3.2.4. By End User 20.5.4. South Africa Market Analysis 20.5.4.1. Introduction 20.5.4.2. Market Analysis and Forecast by Market Taxonomy 20.5.4.2.1. By Product and Services 20.5.4.2.2. By Assay Type 20.5.4.2.3. By Application 20.5.4.2.4. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Branding and Promotional Strategies, By Key Players 22.3. Key Development Analysis 22.4. Competition Deep Dive 22.4.1. Thermo Fisher Scientific 22.4.1.1. Overview 22.4.1.2. Product Portfolio 22.4.1.3. Key Financials 22.4.1.4. Sales Footprint 22.4.1.5. SWOT Analysis 22.4.1.6. Strategy Overview 22.4.1.6.1. Marketing Strategy 22.4.1.6.2. Product Strategy 22.4.1.6.3. Channel Strategy 22.4.2. Bio-Rad Laboratories 22.4.2.1. Overview 22.4.2.2. Product Portfolio 22.4.2.3. Key Financials 22.4.2.4. Sales Footprint 22.4.2.5. SWOT Analysis 22.4.2.6. Strategy Overview 22.4.2.6.1. Marketing Strategy 22.4.2.6.2. Product Strategy 22.4.2.6.3. Channel Strategy 22.4.3. QIAGEN 22.4.3.1. Overview 22.4.3.2. Product Portfolio 22.4.3.3. Key Financials 22.4.3.4. Sales Footprint 22.4.3.5. SWOT Analysis 22.4.3.6. Strategy Overview 22.4.3.6.1. Marketing Strategy 22.4.3.6.2. Product Strategy 22.4.3.6.3. Channel Strategy 22.4.4. Luminex Corporation 22.4.4.1. Overview 22.4.4.2. Product Portfolio 22.4.4.3. Key Financials 22.4.4.4. Sales Footprint 22.4.4.5. SWOT Analysis 22.4.4.6. Strategy Overview 22.4.4.6.1. Marketing Strategy 22.4.4.6.2. Product Strategy 22.4.4.6.3. Channel Strategy 22.4.5. Fluidigm Corporation 22.4.5.1. Overview 22.4.5.2. Product Portfolio 22.4.5.3. Key Financials 22.4.5.4. Sales Footprint 22.4.5.5. SWOT Analysis 22.4.5.6. Strategy Overview 22.4.5.6.1. Marketing Strategy 22.4.5.6.2. Product Strategy 22.4.5.6.3. Channel Strategy 22.4.6. BioFire Diagnostics. 22.4.6.1. Overview 22.4.6.2. Product Portfolio 22.4.6.3. Key Financials 22.4.6.4. Sales Footprint 22.4.6.5. SWOT Analysis 22.4.6.6. Strategy Overview 22.4.6.6.1. Marketing Strategy 22.4.6.6.2. Product Strategy 22.4.6.6.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Multiplex PCR Assays Market
